Key Trends in 2018 in the Biopharmaceutical Market
Interview with Nigel Darby, Advisor, GE Healthcare Life Sciences
Vaccine Industry Retools Itself for Speed
Vaccine Manufacturing Moves toward Mass Customization
Cell Therapy Manufacturing: All Signs Point to Commercialization
As Milestones Are Reached, Best Practices Will Become Less Hazy
Top 10 Best-Selling Cancer Drugs, Q1–Q3 2017
15% Year-Over-Year Growth, with Sales Set to More than Double by 2022
For full access to this article login to GEN Select now.
Cell Culture Central to Upstream Scaleup
Why There's a Good Deal of Truth to the Dictum: "As Cells Go, So Goeth the Process"
- Scaleup trends closely follow the larger bioprocessing industry. According to Christian Kaisermayer, Ph.D., project manager for cell culture at GE Healthcare Life Sciences the two significant drivers are process flexibility and complete solutions. Underlying both trends are the rise in protein titers over the past decade and disposable ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.